Detailed Explanation Of NMPA Registration, Standard System, And Quality Regulatory Compliance Essentials For Disposable Trocars

https://www.lookmedchina.com/resources/disposable-laparoscopic-trocar.html

In China, the Disposable Laparoscopic Trocar (commonly known as disposable trocar) falls under "02-07-02 Laparoscopic Trocar" in the "Medical Device Classification Catalog," managed as a Class II medical device. It must apply for product registration with the provincial drug regulatory department and obtain a "Medical Device Registration Certificate" before being marketed. Declaration materials are compiled according to the "Measures for the Administration of Medical Device Registration and Filing" (State Administration for Market Regulation Order No. 47) and the "Requirements and Instructions for Medical Device Registration Declaration Materials." The core includes: Product Overview (structural diagrams, material grades, specification lists), Research Materials (performance research-puncture force/airtightness/insertion-withdrawal force/fixation force/torque, biological evaluation-per GB/T 16886 series for cytotoxicity, sensitization, intracutaneous reactivity, acute systemic toxicity, hemolysis, pyrogen), Manufacturing Information (process flow chart, key process validation such as electropolishing parameters, EO sterilization validation ISO 11135), Product Technical Requirements (citing YY/T 1710-2020 "Disposable Abdominal Trocar" stipulating appearance, dimensions, connection firmness, puncture performance, sealing performance, evaporation residue, heavy metals, EO residue, sterility, bacterial endotoxin), Test Reports (full-item testing issued by a CMA/CNAS-qualified laboratory), Clinical Evaluation (listed in the "Catalog of Medical Devices Exempt from Clinical Evaluation" 2023 edition; submitting equivalence comparison + literature data exempts clinical trials but requires detailed description of substantial equivalence of comparative devices), Instructions and Labeling Samples (including contraindications "reuse prohibited," warnings "single use only," EO sterilization indicator, allergy alerts for PC/silicone).

Manufacturing enterprises must pass ISO 13485:2016 quality management system certification and accept GMP unannounced inspections by drug regulators. Key audit points include: Raw material supplier audits (stainless steel material certificates, PC pellet FDA DMF/USP Class VI certificates), Process validation (special processes-electropolishing, EO sterilization, cleanroom environmental monitoring), Non-conforming product control, and UDI (Unique Device Identification) coding uploaded to the NMPA database (implemented per "Rules on the Unique Device Identification System for Medical Devices"). Adverse event monitoring requires regular submission of Periodic Safety Update Reports (PSUR) post-marketing; if sealing failure causing pneumoperitoneum loss, obturator fracture, or cannula slippage causing additional incisions occur, they must be reported within stipulated timeframes. Exporting to the EU requires CE Mark (now mostly transitioning to MDR EU 2017/745 Class IIa, notified body review cycle 18–24 months); US FDA 510(k) requires substantial equivalence comparison (typically benchmarking against Ethicon Versaport or Medtronic ENDOPATH XCEL); Canada, Australia, etc., have their respective registration pathways. Compliance is a prerequisite for domestic disposable trocars to enter centralized procurement listings in graded hospitals; enterprises should plan registration strategies in parallel during early R&D stages.